GlassScriptPhysician profile
Zein Kattih
NPI 1750885257
$1,653.40
in general payments reported to CMS, 2019-2025
11 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $633 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $1,001.97 | 2024-2025 | Remodulin, Tyvaso, Orenitram |
| Actelion Pharmaceuticals US, INC. | $175.97 | 2025 | Uptravi, Opsumit, Opsynvi |
| Bayer Healthcare Pharmaceuticals INC. | $109.73 | 2024-2025 | |
| Vifor Pharma, INC. | $95.23 | 2024 | Zemaira |
| Takeda Pharmaceuticals U.S.A., INC. | $86.54 | 2024-2025 | Livtencity |
| Merck Sharp & Dohme LLC | $69.55 | 2024-2025 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.71 | 2025 | Jascayd, Ofev |
| Abiomed | $19.86 | 2024 | Impella |
| Baxter Healthcare | $19.24 | 2025 | Hillrom - Monarch Airway Clearance System |
| Insmed, INC. | $18.85 | 2025 | Brinsupri, Arikayce |
| Vertex Pharmaceuticals Incorporated | $17.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zein Kattih listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.